Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Knightscope
Sponsored
content by Knightscope
MA
MarketJar
Community Contributor
The Next Phase of Defense AI: A Robotic Response to America’s Security Gaps
Autonomous systems are no longer just a futuristic vision — they’re fast becoming an essential layer of national security. As AI reshapes everything from finance to warfare, physical security remains one of the most under-addressed frontiers.
View narrative
US$12.00
FV
50.7% undervalued
intrinsic discount
22.00%
Revenue growth p.a.
Set Fair Value
10
users have liked this narrative
1
users have commented on this narrative
45
users have followed this narrative
8 days ago
author updated this narrative
Figma
TI
TickerTickle
Community Contributor
Figma (FIG): The S&P 500’s Design Standard Turning Into an All-in-One Platform
Watching Figma Grow Up I’ve been using Figma almost every single day for the past five years. As a product designer, it’s been my main tool for designing interfaces, testing and prototyping ideas, and also for working together with teams in different countries and time zones.
View narrative
US$65.70
FV
8.5% overvalued
intrinsic discount
30.00%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
1
users have commented on this narrative
19
users have followed this narrative
Updated
narrative
Sleep Cycle
MA
Mandelman
Community Contributor
Sleep Cycle's Revenue Set to Rise 10% with Strong Revenue Model
Update Q1 2025 (updated 250510) The latest user‐growth data suggest headwinds for top-line revenue, but management’s active repricing initiatives should help offset this. By combining modest user gains with targeted price increases, the company can still drive overall revenue growth.
View narrative
SEK 38.04
FV
18.4% undervalued
intrinsic discount
3.15%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
2
users have commented on this narrative
37
users have followed this narrative
Updated
narrative
JB Hi-Fi
RO
Robbo
Community Contributor
Has JB Hi-Fi Lost Its Point of Difference?
I may be showing my age here, but I feel that a decade or so ago, shopping at JB Hi-Fi was a different experience. There seemed to be a deliberate policy of employing sales staff from alternative subcultures, which gave the stores a unique, edgy vibe.
View narrative
AU$76.00
FV
54.2% overvalued
intrinsic discount
-0.45%
Revenue growth p.a.
Set Fair Value
4
users have liked this narrative
1
users have commented on this narrative
11
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Huntsman
AN
AnalystHighTarget
Consensus Narrative from 13 Analysts
Global Urbanization And Electrification Will Spur Advanced Materials Demand
Key Takeaways Structural cost reductions and streamlined operations position Huntsman for lasting cash generation and resilient margins through economic cycles. Growth in energy-efficient construction and advanced materials, alongside innovation in Asian markets, supports revenue expansion and improved earnings quality.
View narrative
US$17.16
FV
36.5% undervalued
intrinsic discount
5.05%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
New
narrative
Offerpad Solutions
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Digital First Real Estate Solutions Will Open New Markets
Key Takeaways Enhanced digital platform and asset-light services position Offerpad to capitalize on evolving consumer preferences and diversify revenue streams for sustainable earnings growth. Investment in proprietary technology and efficiency initiatives supports improved margins, operational scalability, and flexibility to pursue expansion, even amid challenging market conditions.
View narrative
US$1.28
FV
388.6% overvalued
intrinsic discount
16.17%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
Updated
narrative
Esperion Therapeutics
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Aging Population And Precision Medicine Will Expand Cardiovascular Care
Key Takeaways Surging uptake among statin-intolerant patients and strong international momentum suggest revenue growth and profitability could exceed current consensus expectations. Unique oral therapy positioning, innovative commercial execution, and operational flexibility provide a durable competitive edge and significant growth optionality.
View narrative
US$14.68
FV
84.9% undervalued
intrinsic discount
24.33%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Cronos Group
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Regulatory Shifts In Israel And Germany Will Hinder Cannabis Growth
Key Takeaways Reliance on international markets and regulatory uncertainty could threaten revenue growth and add financial volatility as legal or reimbursement environments shift. Intensifying price competition, ESG scrutiny, and rising operational costs may erode margin improvements and create challenges for sustained profitability.
View narrative
CA$2.90
FV
23.1% overvalued
intrinsic discount
6.49%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
DENTSPLY SIRONA
AN
AnalystHighTarget
Consensus Narrative from 14 Analysts
An Aging Population And Emerging Markets Will Fuel Digital Dentistry
Key Takeaways Acceleration in AI-driven platform adoption and operational streamlining can transform profitability and establish a dominant position in global digital dentistry. International growth opportunities and a focus on innovation position the company to outpace peers, capture new markets, and drive more consistent revenue expansion.
View narrative
US$22.13
FV
35.3% undervalued
intrinsic discount
3.12%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Alto Ingredients
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Global Decarbonization And ISCC Exports Will Drive Bio-Based Success
Key Takeaways Accelerated carbon improvements, strategic exports, and operational flexibility position Alto for substantial recurring earnings gains and reduced volatility amid growing demand for clean-label ingredients. Active asset optimization and potential strategic transactions could unlock hidden value, strengthening the balance sheet and fueling future growth initiatives.
View narrative
US$5.50
FV
79.3% undervalued
intrinsic discount
5.67%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
YouGov
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
AI Automation And First-Party Data Will Secure Global Demand
Key Takeaways YouGov's platform expansion and automation are set to accelerate operating leverage, margin expansion, and recurring revenues beyond current analyst expectations. Enhanced data integration and privacy compliance uniquely position YouGov to win major enterprise contracts, driving revenue acceleration and strengthening long-term client relationships.
View narrative
UK£7.60
FV
54.4% undervalued
intrinsic discount
5.48%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
2373
Beauty Farm Medical and Health Industry
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Chinese Premium Wellness Trends Will Expand Market Opportunities
Key Takeaways Wealth concentration in top cities and secular health trends drive sustained growth in premium beauty and medical aesthetic services, supporting higher margins and market expansion. Digital innovation, high membership-based recurring revenue, and successful M&A integration underpin scalable growth, cost efficiency, and predictable cash flows.
View narrative
HK$37.01
FV
5.2% undervalued
intrinsic discount
12.61%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
New
narrative
Ekso Bionics Holdings
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Enterprise Order Delays Will Weaken Performance But Spark Opportunity
Key Takeaways Regulatory changes and demographic trends support long-term demand, but unpredictable reimbursement and healthcare funding limit near-term revenue growth and cash flow stability. Product and partnership expansion offers diversification, though dependence on delayed enterprise sales and high R&D costs could defer profitability.
View narrative
US$4.00
FV
2.8% undervalued
intrinsic discount
22.28%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Value any company in seconds
Popular companies